minirin melt 60 mcg
ferring pharmaceuticals ltd - desmopressin as acetate - tablets soluble - desmopressin as acetate 60 mcg - desmopressin - desmopressin - nocturnal enuresis.
minirin melt 120 mcg
ferring pharmaceuticals ltd - desmopressin as acetate - tablets soluble - desmopressin as acetate 120 mcg - desmopressin - desmopressin - nocturnal enuresis.
ferring pharmaceuticals rekovelle reusable injection pen
ferring pharmaceuticals private limited - obstetrics & gynaecology - reusable injection pen intended for the administration of subcutaneous injections of rekovelle provided by ferring pharmaceuticals a/s.
rekovelle 12mcg0.36ml solution for injection in pre-filled pen
ferring sdn. bhd. - follitropin delta -
rekovelle 36 mcg1.08 ml solution for injection in pre-filled pen
ferring sdn. bhd. - follitropin delta -
rekovelle 72 mcg2.16 ml solution for injection in pre-filled pen
ferring sdn. bhd. - follitropin delta -
menopur multidose powder and solvent for solution for injection 1200iu
ferring pharmaceuticals private limited - menotrophin, highly purified - injection, powder, for solution - 1200 iu - menotrophin, highly purified 1200 iu/vial
rekovelle 12
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 12 mcg / 0.36 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
rekovelle 36
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 36 mcg / 1.08 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
rekovelle 72
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 72 mcg / 2.16 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol